Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2.

Slides:

Advertisements

Similar presentations

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Advertisements

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Psoriasis: Latitude does make a difference

Baldness reversed by chemotherapy

Bertha Wong, MD, Muhammad M. Mamdani, PharmD, MPH, Catherine H

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD

Ahmad Al Aboud, MD, Melissa Abrams, MD, Anthony J. Mancini, MD

Efficacy of simvastatin in plaque psoriasis: A pilot study

Expression of PD-L1 in mastocytosis

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Clindamycin-induced Sweet syndrome

2 Lt Dane Dicaro, BS, Capt Casey Bowen, MD, LTC Scott R. Dalton, DO

JAK inhibitors in dermatology: The promise of a new drug class

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Katherine E. Brick, BS, Robert H. Cook-Norris, MD, David A

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis Alan Menter, MD, Jennifer C. Cather, MD, Diane.

Assessing adherence with phototherapy protocols

Khanh P. Thieu, BS, Harley A. Haynes, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis Lorinda Chung, MD, David Fiorentino,

Applying for dermatology residency is difficult and expensive

Efficacy of intralesional photodynamic therapy for the treatment of hidradenitis suppurativa Manuel Ángel Rodríguez-Prieto, MD, Luis Miguel Valladares-Narganes,

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Duration of oral antibiotic therapy for the treatment of adult acne: A retrospective analysis investigating adherence to guideline recommendations and.

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: Preliminary data Andrea Paradisi, MD, Giacomo.

Reply to: “A note on normality”

Google search trends for tanning salons: Temporal patterns indicate peak interest in mid spring Derek D. Reed, PhD, BCBA-D Journal of the American Academy.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Fever, eosinophilia, and a rash

Partik Singh, BA, Jonathan I. Silverberg, MD, MPH, PhD

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Infectious rash after riding elephants

Gwanghyun Jo, MD, Je-Ho Mun, MD, PhD

Lip edema Journal of the American Academy of Dermatology

Videodermoscopy of the hyponychium in nail bed psoriasis

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Leflunomide as adjuvant treatment of dermatomyositis

Varicella zoster virus–associated generalized pustular psoriasis in a baby with heterozygous IL36RN mutation Kazumitsu Sugiura, MD, PhD, Ryuhei Uchiyama,

Hugh Gloster, MD, Chesahna Kindred, MBA

Seasonal patterns in alopecia areata, totalis, and universalis

Appearance of lentigines in psoriasis patients treated with apremilast

Medicaid acceptance among pediatric dermatologists

Increased risks of autoimmune rheumatic diseases in patients with psoriasis: A nationwide population-based study Hyun Jeong Ju, MD, Ki-Jo Kim, MD, PhD,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Derek Y. Hsu, BA, Kenneth Gordon, MD, Jonathan I

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,

A new oral anticoagulant in the setting of dermatologic surgery

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Anastasia O. Kurta, DO, Daisy Dai, PhD, Eric S

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus Carlos G. Wambier, MD, Maria C. Foss-Freitas, MD, PhD, Renato S. Paschoal, MD, Marilia V. Tomazini, MD, João C. Simão, MD, Milton C. Foss, MD, PhD, Norma T. Foss, MD, PhD Journal of the American Academy of Dermatology Volume 60, Issue 5, Pages 883-885 (May 2009) DOI: 10.1016/j.jaad.2008.10.009 Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Capillary blood glucose measurements from the hospitalization days 28 to 46. Note the need for several intravenous infusions of hypertonic glucose to maintain adequate blood glucose levels. Adequate glycemic control was obtained during the last week of hospitalization even though insulin therapy was discontinued. Journal of the American Academy of Dermatology 2009 60, 883-885DOI: (10.1016/j.jaad.2008.10.009) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions